The US Food and Drug Administration approved an emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine on Friday, clearing the way for the distribution of the drug across the country.
According to The NYT reports, an initial shipment of about 2.9 million doses of the vaccine will be sent around the US over the next week.
“About 3 million doses of the Pfizer-BioNTech vaccine are expected in the first shipments around the country, according to officials with Operation Warp Speed, the Trump administration’s vaccine development program. A similar amount is to be held in reserve for those recipients’ second dose.” — AP
Today, FDA issued the first emergency use authorization (EUA) for a vaccine for the prevention of #COVID19 caused by SARS-CoV-2 in individuals 16 years of age and older. The emergency use authorization allows the vaccine to be distributed in the U.S. https://t.co/1Vu0xQqmCB pic.twitter.com/c8maeePP9O
— U.S. FDA (@US_FDA) December 12, 2020
The FDA will recommend who receives the vaccine first and is expected to prioritize frontline health care workers and nursing home residents
BREAKING NEWS! CNN confirms the FDA has officially given the green light for the emergency use authorization of the Pfizer Coronavirus vaccine. Dr. Sanjay Gupta & Dr. Leana Wen are discussing on @CuomoPrimeTime now! pic.twitter.com/gd0y9fKgRW
— Christopher C. Cuomo (@ChrisCuomo) December 12, 2020